Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of the trial is to demonstrate superiority of Pergoveris® versus GONAL-f® in poor ovarian response (POR) patients.
Inclusion criteria
- Poor Ovarian Response i.e. a failure to respond adequately to standard ART (assisted reproductive technologies) protocols and to recruit adequate follicles